Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer

By sjmartinez • April 30, 2024

Shin DS, Basak S, Veena MS, Comin-Anduix B, Bhattacharya A, Dong TS, Ko A, Han P, Jacobs J, Moatamed NA, Avila L, Pellegrini M, Wang M, Srivatsan ES. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer Med. 2024 May;13(9):e7212. doi: 10.1002/cam4.7212. PMID: 38686626; PMCID: PMC11058674.

Tags: APG‐157, Digestive Diseases, Head and neck cancer, Hematology/Oncology, immune checkpoint inhibitors, microbiome, Publications, tumor microenvironment, Veterans Administration

Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial

May FP, Brodney S, Tuan JJ, Syngal S, Chan AT, Glenn B, Johnson G, Chang Y, Drew DA, Moy B, Rodriguez NJ, Warner ET, Anyane-Yeboa[...]

Integrated behavioral care in general hepatology increases alcohol use disorder treatment in veterans

Perumalswami PV, Cornwell BL, Grau PP, Meyers AC, Jayaram M, Irani S, Wongsirisakul P, Liangpunsakul S, Patel A, DePhilippis D, Liberto J, Szymanski BR, McCarthy[...]

Patient-Reported Barriers to On-Time Surveillance After Successful Endoscopic Eradication of Barrett’s Esophagus Neoplasia: A Multicenter Qualitative Interview Study

Kahn A, Paul MM, Kolb JM, Brown B, Eluri S, Leggett CL, Codipilly DC, Ramirez FC, Iyer PG. Patient-Reported Barriers to On-Time Surveillance After Successful[...]